| Patents for C07K 9 - Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof (3,306) |
|---|
| 02/07/2013 | US20130034557 Cancer-Related Glycopeptide Epitopes, Antibodies And Methods Of Use |
| 02/07/2013 | US20130034556 Free hexasaccharide isolated from several campylobacter species |
| 01/31/2013 | US20130030151 Rapid glycopeptide optimization via neoglycosylation |
| 01/31/2013 | US20130029901 Methods and compounds for the targeted delivery of agents to bone for interaction therewith |
| 01/29/2013 | US8361961 O-linked glycosylation of peptides |
| 01/29/2013 | US8361476 With a carrier peptide adjuvant that is able to strongly enhance the immune response to a specific co-administered antigen |
| 01/24/2013 | US20130023643 Nuclear localization signal peptides derived from vp2 protein of chicken anemia virus and uses of said peptides |
| 01/22/2013 | US8357494 Anti-clusterin oligoclonal antibodies for diagnosis and prediction of the aggressiveness of tumours, diagnostic method and related kits |
| 01/16/2013 | EP2545081A1 Free hexasaccharide isolated from several campylobacter species |
| 01/10/2013 | US20130012456 Compositions and methods for transport across the blood brain barrier |
| 01/09/2013 | CN102863519A Refining method for vancomycin hydrochloride |
| 01/08/2013 | CA2559188C Hyaluronic acid-methotrexate conjugate |
| 01/03/2013 | US20130005648 Peptide compositions and methods for inhibiting herpesvirus infection |
| 01/03/2013 | US20130004513 Agents for treating disease |
| 01/02/2013 | CN102850442A 糖肽 Glycopeptides |
| 12/27/2012 | US20120329727 Treatment of uncoupling protein 2 (ucp2) related diseases by inhibition of natural antisense transcript to ucp2 |
| 12/26/2012 | CN102838662A Preparation method of high purity ramoplanin single components |
| 12/26/2012 | CN102838661A Vancomycin or demethyl vancomycin analogue and medicinal uses thereof |
| 12/25/2012 | US8338372 Dehydroxy vancomycin, the preparation, pharmaceutical composition and the use |
| 12/25/2012 | US8338140 Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites |
| 12/20/2012 | US20120322724 Molecules for targeting compounds to various selected organs or tissues |
| 12/19/2012 | CN102827256A Preparation and application of ginseng glycoprotein |
| 12/13/2012 | WO2012170491A1 Glycan and glycopeptide capture and release using reversible hydrazone-based method |
| 12/06/2012 | US20120309684 Conjugates for delivery of biologically active compounds |
| 12/06/2012 | US20120308646 Tetracyclic anthraquinones possessing anti-cancer properties |
| 11/28/2012 | CN101838316B Method for preprocessing Ramoplanin fermentation liquor |
| 11/20/2012 | US8314217 Cross-linked glycopeptide-cephalosporin antibiotics |
| 11/15/2012 | US20120289457 Peptide oligonucleotide conjugates |
| 11/08/2012 | US20120283195 Glycopeptide phosphonate derivatives |
| 11/07/2012 | CN102766198A Glycopeptide antifungal compound, and preparation method and application thereof |
| 11/06/2012 | US8303956 Glycosylated specificity exchangers |
| 11/01/2012 | US20120277158 Compositions and methods for the transport of therapeutic agents |
| 11/01/2012 | US20120276136 Chemically programmable immunity |
| 10/31/2012 | CN102757992A Method for enriching glycopeptide with combination of polyethylene glycol coupling and ultrafiltration centrifugal separation |
| 10/30/2012 | US8299206 Method of synthesis of morpholino oligomers |
| 10/26/2012 | WO2012142659A1 Site-selective modification of proteins |
| 10/25/2012 | US20120270768 Tumor Activated Prodrugs |
| 10/25/2012 | US20120270238 Peptides That Bind the Alpha-Fetoprotein (AFP) Receptor and Uses Thereof |
| 10/24/2012 | CN101031582B Purification of glycopeptides |
| 10/18/2012 | WO2012139777A1 Method for the rapid chemoenzymatic glycosylation of conjugates between peptides and hydrophilic polymers |
| 10/18/2012 | US20120263759 Coating Comprising An Elastin-Based Copolymer |
| 10/18/2012 | US20120263740 Aptamer-targeted sirna to inhibit nonsense mediated decay |
| 10/17/2012 | EP2511289A1 Method for the rapid chemoenzymatic glycosylation of conjugates between peptides and hydrophilic polymers |
| 10/17/2012 | CN102731628A Method for preparing romurtide |
| 10/17/2012 | CN101838315B Method for separating Ramoplanin |
| 10/17/2012 | CN101440127B Preparation of high-purity vancomycin hydrochloride |
| 10/17/2012 | CN101423547B Purification method of teicoplanin |
| 10/10/2012 | CN102718843A Preparation method of single teicoplanin components |
| 10/04/2012 | WO2012094627A3 Method of production of recombinant glycoproteins with increased circulatory half-life in mammalian cells |
| 10/04/2012 | US20120252869 Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt) |
| 10/04/2012 | US20120252741 Novel semi-synthetic glycopeptides as antibacterial agents |
| 10/03/2012 | CN101851277B Preparation method of Dalbavancin key intermediate A40926 BO component by purification |
| 09/27/2012 | US20120244136 Cardiac-Specific Protein Targeting Domain |
| 09/26/2012 | CN102695716A Sugar chain marker as measure of disease conditions of hepatic diseases |
| 09/26/2012 | CN102695715A Inhibitors of viral integrase and methods of use |
| 09/26/2012 | CN102690333A Preparation method of high-purity teicoplanin |
| 09/26/2012 | CN102690332A Novel glycopeptide antibiotic derivative and pharmaceutical composition, and preparation method and purpose thereof |
| 09/26/2012 | CN102690331A Monosaccharide glycopeptide derivative, pharmaceutical composition, preparation method and purpose thereof and preparation method of intermediate |
| 09/26/2012 | CN102690330A Tri-substituted glycopeptide derivative and pharmaceutical composition, and preparation method and purpose thereof |
| 09/20/2012 | WO2012123926A1 Method for preparing multiple antigen glycopeptide carbohydrate conjugates |
| 09/20/2012 | CA2828688A1 Method for preparing multiple antigen glycopeptide carbohydrate conjugates |
| 09/19/2012 | EP2500033A1 Method for preparing muliple antigen glycopeptide carbohydrate conjugates |
| 09/05/2012 | EP2495251A1 Hydrochloride salts of a glycopeptide phosphonate derivative |
| 09/04/2012 | US8258101 Peptide-based compounds |
| 08/30/2012 | US20120220517 Glycopegylation Methods and Proteins/Peptides Produced by the Methods |
| 08/30/2012 | US20120219573 Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids |
| 08/23/2012 | US20120214967 Cross-linked glycopeptide-cephalosporin antibiotics |
| 08/21/2012 | US8247211 Glycopeptide antibiotics |
| 08/16/2012 | US20120208771 Synthetic cholesterylamine-linker derivatives for agent delivery into cells |
| 08/16/2012 | US20120208720 Rapid display method in translational synthesis of peptide |
| 08/16/2012 | US20120208225 Modified peptide substrate |
| 08/15/2012 | CN101341167B Process for the purification of macrolide antibiotics |
| 08/09/2012 | US20120202983 Conjugates and Compositions for Cellular Delivery |
| 08/09/2012 | US20120202733 Inhibition of trem receptor signaling with peptide variants |
| 08/07/2012 | US8236756 Prodrugs cleavable by CD26 |
| 07/26/2012 | US20120190097 Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same |
| 07/25/2012 | CN102603872A Application of monodisperse polymethacrylate mixed type cation exchange chromatography media to vancomycin purification by column chromatography |
| 07/12/2012 | WO2012094627A2 Method of production of recombinant glycoproteins with increased circulatory half-life in mammalian cells |
| 07/12/2012 | WO2011156751A3 Immunogenic vaccine |
| 07/12/2012 | CA2817765A1 Method of production of recombinant glycoproteins with increased circulatory half-life in mammalian cells |
| 07/11/2012 | EP2474560A1 Method for producing 11-sugar sialyloligosaccharide-peptide |
| 07/10/2012 | CA2462930C Remodeling and glycoconjugation of peptides |
| 07/05/2012 | US20120171253 Fibromodulin Peptide |
| 07/04/2012 | CN1964736B Dalbavancin compositions for treatment of bacterial infections |
| 07/04/2012 | CN102532277A Agricultural antibiotic polyoxin P, biosynthesis method and application thereof |
| 06/28/2012 | WO2012085221A1 Derivatives of glyco-cf2-serine and glyco-cf2-threonine |
| 06/28/2012 | US20120165504 Vancomycin b hydrochloride crystalline form 1 |
| 06/28/2012 | US20120165228 Evolving new molecular function |
| 06/28/2012 | CA2822097A1 Derivatives of glyco-cf2-serine and glyco-cf2-threonine |
| 06/14/2012 | US20120149869 Alpha-conotoxin peptides |
| 06/14/2012 | US20120149632 Glycopeptide and lipoglycopeptide antibiotics with improved solubility |
| 06/14/2012 | US20120149053 Carrier peptide fragment and use thereof |
| 06/14/2012 | US20120148502 Carbohydrate-Mediated Tumor Targeting |
| 06/07/2012 | US20120141590 Technology for the Preparation of Microparticles |
| 06/06/2012 | EP2459708A1 H. pylori lipopolysaccharide outer core epitope |
| 05/31/2012 | US20120135919 Polymer-drug conjugates |
| 05/31/2012 | US20120135912 Polypeptide inhibitors of vla4 |
| 05/31/2012 | US20120134931 Peptides whose uptake in cells is controllable |
| 05/30/2012 | CN102482646A 幽门螺杆菌脂多糖外部核心表位 Helicobacter pylori lipopolysaccharide external core epitope |
| 05/29/2012 | US8188247 Conjugates and compositions for cellular delivery |